 NEWARK, Calif., Sept. 22, 2021 GLOBE NEWSWIRE -- Rain Therapeutics Inc. NasdaqGS: RAIN, Rain, a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the Cantor Fitzgerald Virtual Global Healthcare Conference being held virtually September 27-30, 2021. 